Healthcare -
Biotechnology - NASDAQ - US
$ 0.0144
20 %
$ 2.39 M
Market Cap
-0.04
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Ocean Biomedical, Inc.
| Net Income | -9.48 M |
| Depreciation & Amortization | 0 |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 745 K |
| Change in Working Capital | 1.04 M |
| Others | 3.69 M |
| Free Cash Flow | -4.18 M |
Cash Flow
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||
| Net Income | (9.5) | (114.5) | (1.0) | (62.3) | (1.7) | (0.2) |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 0.7 | 1.2 | 0 | 56.5 | 0 | 0 |
| Other Operating Activities | 3.5 | 102.7 | (1.5) | 2.45 K | 0 | 0 |
| Change in Working Capital | 1.0 | 1.2 | 1.7 | 4.7 | 1.6 | 0.2 |
| Cash From Operations | (4.2) | (9.4) | (0.7) | (1.1) | 64 K | 0 |
| INVESTING CASH FLOW | ||||||
| Capital Expenditures | 0 | 0 | 3 | 0 | 0 | 0 |
| Other Items | 0 | 0 | (2.1) | (107.1) | 0 | 0 |
| Cash From Investing Activities | 0 | 0 | (2.1) | (107.1) | 0 | 0 |
| FINANCING CASH FLOW | ||||||
| Common Stock Repurchased | 0 | (64.3) | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 6.8 | 2.1 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 3.4 | 52.1 | 0 | 96 K | 64 K | 0 |
| Cash From Financing Activities | 3.4 | 10.4 | 2.1 | 1.1 | 64 K | 0 |
| CHANGE IN CASH | ||||||
| Net Change In Cash | (0.8) | 1.0 | (0.7) | 60 K | 0 | 0 |
| FREE CASH FLOW | ||||||
| Free Cash Flow | (4.2) | (9.4) | (0.7) | (1.1) | 64 K | 0 |